Literature DB >> 27959742

Nephron Protection in Diabetic Kidney Disease.

Hans-Joachim Anders1, John M Davis1, Klaus Thurau1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27959742     DOI： 10.1056/NEJMcibr1608564

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

Review 1.  SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases.

Authors:  Christoph Wanner; Nikolaus Marx
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

Review 2.  Diuretic Treatment in Heart Failure.

Authors:  David H Ellison; G Michael Felker
Journal:  N Engl J Med       Date:  2017-11-16       Impact factor: 91.245

3.  Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin.

Authors:  Manga Motrapu; Monika Katarzyna Świderska; Irene Mesas; Julian Aurelio Marschner; Yutian Lei; Laura Martinez Valenzuela; Jia Fu; Kyung Lee; Maria Lucia Angelotti; Giulia Antonelli; Paola Romagnani; Hans-Joachim Anders; Lidia Anguiano
Journal:  J Am Soc Nephrol       Date:  2020-06-23       Impact factor: 10.121

4.  A Heartwarming Role of the Proximal Tubules.

Authors:  Michael L Granda; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2022-02       Impact factor: 8.237

5.  Acute and chronic kidney complications in children with type 1 diabetes mellitus.

Authors:  Giulio Rivetti; Brenden E Hursh; Emanuele Miraglia Del Giudice; Pierluigi Marzuillo
Journal:  Pediatr Nephrol       Date:  2022-07-27       Impact factor: 3.651

Review 6.  Nephron overload as a therapeutic target to maximize kidney lifespan.

Authors:  Valerie A Luyckx; Andrew D Rule; Katherine R Tuttle; Pierre Delanaye; Helen Liapis; Afschin Gandjour; Paola Romagnani; Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2021-12-08       Impact factor: 42.439

Review 7.  Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Veli-Pekka Harjola; Wilfried Mullens; Marek Banaszewski; Johann Bauersachs; Hans-Peter Brunner-La Rocca; Ovidiu Chioncel; Sean P Collins; Wolfram Doehner; Gerasimos S Filippatos; Andreas J Flammer; Valentin Fuhrmann; Mitja Lainscak; Johan Lassus; Matthieu Legrand; Josep Masip; Christian Mueller; Zoltán Papp; John Parissis; Elke Platz; Alain Rudiger; Frank Ruschitzka; Andreas Schäfer; Petar M Seferovic; Hadi Skouri; Mehmet Birhan Yilmaz; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2017-05-30       Impact factor: 15.534

8.  Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!

Authors:  Vajir Malek; Sachin V Suryavanshi; Nisha Sharma; Yogesh A Kulkarni; Shrikant R Mulay; Anil Bhanudas Gaikwad
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

9.  SGLT2 inhibitors, hemodynamics, and kidney protection.

Authors:  David H Ellison
Journal:  Am J Physiol Renal Physiol       Date:  2021-03-22

10.  Nephron-deficient HSRA rats exhibit renal injury with age but have limited renal damage from streptozotocin-induced hyperglycemia.

Authors:  Meredith B Cobb; Wenjie Wu; Esinam M Attipoe; Ashley C Johnson; Michael R Garrett
Journal:  Am J Physiol Renal Physiol       Date:  2021-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.